Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Christine L Baker, Yao Ding, Cheryl P Ferrufino, Stacey Kowal, Jenen Tan & Prasun Subedi. (2018) A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective. ClinicoEconomics and Outcomes Research 10, pages 359-370.
Read now
Read now
Jacques Le Houezec & Henri-Jean Aubin. (2013) Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence. Expert Opinion on Pharmacotherapy 14:14, pages 1959-1967.
Read now
Read now
N Robson. (2011) Varenicline: a new pharmacotherapy for smoking cessation in primary care practice. South African Family Practice 53:3, pages 217-222.
Read now
Read now
José Juan Escobar-Chávez, Virginia Merino, Octavio Díez-Sales, Amparo Nácher-Alonso, Adriana Ganem-Quintanar, Marina Herráez & Matilde Merino-Sanjuán. (2011) Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation. Pharmaceutical Development and Technology 16:2, pages 162-169.
Read now
Read now
José Juan Escobar-Chávez, Clara Luisa Domínguez-Delgado & Isabel Marlen Rodríguez-Cruz. (2011) Targeting nicotine addiction: the possibility of a therapeutic vaccine. Drug Design, Development and Therapy 5, pages 211-224.
Read now
Read now
Kari Linden, Vesa Jormanainen, Miika Linna, Harri Sintonen, Koo Wilson & Teija Kotomäki. (2010) Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers. Current Medical Research and Opinion 26:3, pages 549-560.
Read now
Read now
Natalya M. Kogan & Raphael Mechoulam. (2007) Cannabinoids in health and disease. Dialogues in Clinical Neuroscience 9:4, pages 413-430.
Read now
Read now
Robert A Schnoll & Caryn Lerman. (2006) Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opinion on Emerging Drugs 11:3, pages 429-444.
Read now
Read now
Jonathan Foulds$suffix/text()$suffix/text(), Jonathan Foulds$suffix/text()$suffix/text(), Michael B. Steinberg, Jonathan Foulds$suffix/text()$suffix/text(), Michael B. Steinberg, Jill M. Williams, Jonathan Foulds$suffix/text()$suffix/text(), Michael B. Steinberg, Jill M. Williams, Douglas M. Ziedonis, Jonathan Foulds$suffix/text()$suffix/text(), Michael B. Steinberg, Jill M. Williams & Douglas M. Ziedonis. (2006) Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug and Alcohol Review 25:1, pages 59-71.
Read now
Read now
Articles from other publishers (73)
Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman & Nicola Lindson. (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023:6.
Crossref
Crossref
Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman & Nicola Lindson. (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Crossref
Ghulam Yahya Amiry, Murtaza Haidary, Hassan Azhdari-Zarmehri, Farimah Beheshti & S. Mohammad Ahmadi-Soleimani. (2023) Omega-3 fatty acids prevent nicotine withdrawal-induced exacerbation of anxiety and depression by affecting oxidative stress balance, inflammatory response, BDNF and serotonin metabolism in rats. European Journal of Pharmacology, pages 175634.
Crossref
Crossref
Jirapornchai Suksaeree, Benjarut Chaichawawut, Muntira Srichan, Noppamon Tanaboonsuthi, Chaowalit Monton, Pattwat Maneewattanapinyo & Wiwat Pichayakorn. (2021) Applying design of experiments (DoE) on the properties of buccal film for nicotine delivery. e-Polymers 21:1, pages 566-574.
Crossref
Crossref
Mahmoud Elsaid YoussefYasser MoustafaHeba Abdelrazek. (2021) Molecular mechanisms of α7-nAchR-mediated anti-inflammatory effects. Indian Journal of Physiology and Pharmacology 64, pages 158-173.
Crossref
Crossref
Shahram Ghorbani Behnam, Seyed Abbas Mousavi & Mohammad Hassan Emamian. (2020) The effects of transcranial direct current stimulation compared to standard bupropion for the treatment of tobacco dependence: A randomized sham-controlled trial. European Psychiatry 60, pages 41-48.
Crossref
Crossref
Leopold Hermle, Christiane Bessey, Nenad Vasic, Kay Uwe Petersen & Anil Batra. (2019) Tabakentwöhnungsbehandlung bei Heimbewohnern mit schweren psychischen Störungen (SMI). SUCHT 65:1, pages 13-21.
Crossref
Crossref
Anusha Rangare Lakshman, Nilofer Halim, Chaithra Kalkur, Amithash RL, Apoorva Mithrananda & Sham Kishor Kannepady. (2018) Nicotine replacement therapy: a treatment angle for oral diagnostician. Journal of Otolaryngology-ENT Research 10:6.
Crossref
Crossref
Nieves Gómez-Coronado, Adam J. Walker, Michael Berk & Seetal Dodd. (2018) Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38:2, pages 235-258.
Crossref
Crossref
Christine L. Baker, Cheryl P. Ferrufino, Marianna Bruno & Stacey Kowal. (2016) Estimated Budget Impact of Adopting the Affordable Care Act’s Required Smoking Cessation Coverage on United States Healthcare Payers. Advances in Therapy 34:1, pages 156-170.
Crossref
Crossref
Emma Beard, Lion Shahab, Damian M. Cummings, Susan Michie & Robert West. (2016) New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?. CNS Drugs 30:10, pages 951-983.
Crossref
Crossref
Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe & Tim Lancaster. (2016) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews.
Crossref
Crossref
M. von Wartburg, V. Raymond & P. E. Paradis. (2014) The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada. International Journal of Clinical Practice 68:5, pages 639-646.
Crossref
Crossref
Henri-Jean Aubin, Amandine Luquiens & Ivan Berlin. (2014) Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. British Journal of Clinical Pharmacology 77:2, pages 324-336.
Crossref
Crossref
Jacques Rouden, Marie-Claire Lasne, Jérôme Blanchet & Jérôme Baudoux. (2013) (−)-Cytisine and Derivatives: Synthesis, Reactivity, and Applications. Chemical Reviews 114:1, pages 712-778.
Crossref
Crossref
P. Garrido, A. Prat, I. Crespo, A. Valverde & E. Salvador. (2012) Vacunas para la deshabituación tabáquica. Vacunas 13:4, pages 163-170.
Crossref
Crossref
Kostas Athanasakis, Michael Igoumenidis, Eleftheria Karampli, Elli Vitsou, Georgia Sykara & John Kyriopoulos. (2012) Cost-Effectiveness of Varenicline Versus Bupropion, Nicotine-Replacement Therapy, and Unaided Cessation in Greece. Clinical Therapeutics 34:8, pages 1803-1814.
Crossref
Crossref
Pasquale Caponnetto, Cristina Russo & Riccardo Polosa. (2012) Smoking cessation: present status and future perspectives. Current Opinion in Pharmacology 12:3, pages 229-237.
Crossref
Crossref
Kate Cahill, Lindsay F Stead & Tim Lancaster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
J. Weil, J. Stritzke & H. Schunkert. (2011) Risikofaktor „Rauchen“Risk factor “smoking”. Der Internist 53:1, pages 45-50.
Crossref
Crossref
David C.L. Lam & John D. Minna. (2011) How Do We Safely Get People to Stop Smoking?. Cancer Prevention Research 4:11, pages 1724-1727.
Crossref
Crossref
N. Vasic, R.C. Wolf, N. Wolf, B.J. Connemann & Z. Sosic-Vasic. (2011) Pharmakologische Strategien zur Unterstützung einer RaucherentwöhnungPharmacotherapeutic treatment strategies for smoking cessation. Der Nervenarzt 82:11, pages 1449-1459.
Crossref
Crossref
James G. Xenakis, Elizabeth T. Kinter, K. Jack Ishak, Alexandra J. Ward, Jenő P. Marton, Richard J. Willke, Simon Davies & J. Jaime Caro. (2011) A Discrete-Event Simulation of Smoking-Cessation Strategies Based on Varenicline Pivotal Trial Data. PharmacoEconomics 29:6, pages 497-510.
Crossref
Crossref
Riccardo Polosa & Neal L. Benowitz. (2011) Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends in Pharmacological Sciences 32:5, pages 281-289.
Crossref
Crossref
Kate Cahill, Lindsay F Stead & Tim Lancaster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Arunabh Talwar, Virginia Reichert & Kalpalatha Guntupalli. 2011. COPD. COPD
149
165
.
Kate Cahill, Lindsay F Stead & Tim Lancaster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Giuseppina Casella, Pasquale Caponnetto & Riccardo Polosa. (2010) Therapeutic advances in the treatment of nicotine addiction: present and future. Therapeutic Advances in Chronic Disease 1:3, pages 95-106.
Crossref
Crossref
Lisa J. Merlo, Kimberly G. Blumenthal, Kendall Campbell, Morrow Omli & Mark S. Gold. 2010. Addictive Disorders in Medical Populations. Addictive Disorders in Medical Populations
503
523
.
Gillian M. Keating & Katherine A. Lyseng-Williamson. (2010) Varenicline. PharmacoEconomics 28:3, pages 231-254.
Crossref
Crossref
Orla McBride, David R. Strong & Christopher W. Kahler. (2010) Exploring the role of a nicotine quantity–frequency use criterion in the classification of nicotine dependence and the stability of a nicotine dependence continuum over time. Nicotine & Tobacco Research 12:3, pages 207-216.
Crossref
Crossref
Michael Jan, Shu Meng, Natalie C. Chen, Jietang Mai, Hong Wang & Xiao-Feng Yang. (2010) Inflammatory and Autoimmune Reactions in Atherosclerosis and Vaccine Design Informatics. Journal of Biomedicine and Biotechnology 2010, pages 1-16.
Crossref
Crossref
Gustavo L. Kortmann, Cristina J. Dobler, Lisiane Bizarro & Claiton H.D. Bau. (2009) Pharmacogenetics of smoking cessation therapy. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153B:1, pages 17-28.
Crossref
Crossref
Lieven Annemans, Kristiaan Nackaerts, Pierre Bartsch, Jacques Prignot & Sophie Marbaix. (2009) Cost Effectiveness of Varenicline in Belgium, Compared with Bupropion, Nicotine Replacement Therapy, Brief Counselling and Unaided Smoking Cessation. Clinical Drug Investigation 29:10, pages 655-665.
Crossref
Crossref
William H. Frishman. (2009) Smoking cessation pharmacotherapy. Therapeutic Advances in Cardiovascular Disease 3:4, pages 287-308.
Crossref
Crossref
Kate Cahill, Lindsay Stead & Tim Lancaster. (2009) A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation. Drug Safety 32:2, pages 119-135.
Crossref
Crossref
Elizabeth Riley, Vijaya Dasari, William H. Frishman & Kirk Sperber. (2008) Vaccines in Development to Prevent and Treat Atherosclerotic Disease. Cardiology in Review 16:6, pages 288-300.
Crossref
Crossref
Kate Cahill, Lindsay F Stead & Tim Lancaster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Hayden McRobbie & Simon Thornley. (2008) La importancia de tratar la dependencia tabáquica. Revista Española de Cardiología 61:6, pages 620-628.
Crossref
Crossref
Mitchell Nides. (2008) Update on Pharmacologic Options for Smoking Cessation Treatment. The American Journal of Medicine 121:4, pages S20-S31.
Crossref
Crossref
Paul Howard, Christopher Knight, Annabel Boler & Christine Baker. (2008) Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model. PharmacoEconomics 26:6, pages 497-511.
Crossref
Crossref
Hayden McRobbie & Simon Thornley. (2008) Cardiovascular Prevention (IV) The Importance of Treating Tobacco Dependence. Revista Española de Cardiología (English Edition) 61:6, pages 620-628.
Crossref
Crossref
Joni L. Rutter. 2008. Drug Addiction. Drug Addiction
69
86
.
A. P. Prestes, F. Z. C. Marques, M. H. Hutz, T. Roman & C. H. D. Bau. (2007) Tobacco smoking and the ADRA2A C-1291G polymorphism. Journal of Neural Transmission 114:11, pages 1503-1506.
Crossref
Crossref
Jennifer L. Oliver, Ghazaleh Pashmi, Paul Barnett, Pascal Mettens, Ralph Biemans, Philippe Monteyne, Rémi Palmantier, Timothy Gallagher, Sharn Ramaya & Susan Wonnacott. (2007) Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies. Vaccine 25:42, pages 7354-7362.
Crossref
Crossref
Lynn T. Kozlowski, Gary A. Giovino, Beth Edwards, Joseph DiFranza, Jonathan Foulds, Richard Hurt, Raymond Niaura, David P.L. Sachs, Peter Selby, Katherine M. Dollar, Deborah Bowen, K. Michael Cummings, Mona Counts, Brion Fox, David Sweanor & Frank Ahern. (2007) Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addictive Behaviors 32:10, pages 2140-2150.
Crossref
Crossref
Nicola A. Hanania & Amir Sharafkhaneh. (2007) Update on the Pharmacologic Therapy for Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 28:3, pages 589-607.
Crossref
Crossref
Candice L. Garwood & Lisa A. Potts. (2007) Emerging pharmacotherapies for smoking cessation. American Journal of Health-System Pharmacy 64:16, pages 1693-1698.
Crossref
Crossref
Rachel F. Tyndale, Jennifer I. Payne, Alexandra L. Gerber & Jack C. Sipe. (2007) The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: Studies of drug use and dependence in caucasians. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B:5, pages 660-666.
Crossref
Crossref
M. Novella Romanelli, Paola Gratteri, Luca Guandalini, Elisabetta Martini, Claudia Bonaccini & Fulvio Gualtieri. (2007) Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential. ChemMedChem 2:6, pages 746-767.
Crossref
Crossref
I. Mitrouska, I. Bouloukaki & N.M. Siafakas. (2007) Pharmacological approaches to smoking cessation. Pulmonary Pharmacology & Therapeutics 20:3, pages 220-232.
Crossref
Crossref
K Cahill, LF Stead & T Lancaster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Mark R. Dyer, Wolfgang A. Renner & Martin F. Bachmann. (2006) A second vaccine revolution for the new epidemics of the 21st century. Drug Discovery Today 11:21-22, pages 1028-1033.
Crossref
Crossref
Steven L. Bernstein, Edwin D. Boudreaux, Rita K. Cydulka, Karin V. Rhodes, Nadine A. Lettman, Sherri-Lynne Almeida, Lynne B. McCullough, Selma Mizouni & Arthur L. Kellermann. (2006) Tobacco Control Interventions in the Emergency Department: A Joint Statement of Emergency Medicine Organizations. Journal of Emergency Nursing 32:5, pages 370-381.
Crossref
Crossref
Steven L. Bernstein, Edwin D. Boudreaux, Rita K. Cydulka, Karin V. Rhodes, Nadine A. Lettman, Sherri-Lynne Almeida, Lynne B. McCullough, Selma Mizouni & Arthur L. Kellermann. (2006) Tobacco Control Interventions in the Emergency Department: A Joint Statement of Emergency Medicine Organizations. Annals of Emergency Medicine 48:4, pages e417-e426.
Crossref
Crossref
Nina G. Schneider, Margaret A. Koury, Chris Cortner, Richard E. Olmstead, Neil Hartman, Leonard Kleinman, Andrew Kim, Craig Chaya & David Leaf. (2006) Preferences among four combination nicotine treatments. Psychopharmacology 187:4, pages 476-485.
Crossref
Crossref
Jed Rose. 2006. Medication Treatments for Nicotine Dependence. Medication Treatments for Nicotine Dependence
63
74
.
Ivan Montoya & Frank Vocci. 2006. Medication Treatments for Nicotine Dependence. Medication Treatments for Nicotine Dependence
293
302
.
J. Foulds. (2006) The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. International Journal of Clinical Practice 60:5, pages 571-576.
Crossref
Crossref
Joni L. Rutter. (2006) Symbiotic relationship of pharmacogenetics and drugs of abuse. The AAPS Journal 8:1, pages E174-E184.
Crossref
Crossref
William H. Frishman, Walter Mitta, Adam Kupersmith & Tom Ky. (2006) Nicotine and Non-nicotine Smoking Cessation Pharmacotherapies. Cardiology in Review 14:2, pages 57-73.
Crossref
Crossref
Martha L Daviglus, Donald M Lloyd-Jones & Amber Pirzada. (2006) Preventing Cardiovascular Disease in the 21st Century. American Journal of Cardiovascular Drugs 6:2, pages 87-101.
Crossref
Crossref
Joel D. Killen, Stephen P. Fortmann, Greer M. Murphy, Chris Hayward, Christina Arredondo, DeAnn Cromp, Maria Celio, Laurie Abe, Yun Wang & Alan F. Schatzberg. (2006) Extended treatment with bupropion SR for cigarette smoking cessation.. Journal of Consulting and Clinical Psychology 74:2, pages 286-294.
Crossref
Crossref
Walton SumnerIIII. (2005) Permissive nicotine regulation as a complement to traditional tobacco control. BMC Public Health 5:1.
Crossref
Crossref
Peter Greenwald. (2005) The Future of Cancer Prevention. Seminars in Oncology Nursing 21:4, pages 296-298.
Crossref
Crossref
Robert M. Anthenelli. (2005) Recent advances in the treatment of tobacco dependence. Clinical Neuroscience Research 5:2-4, pages 175-183.
Crossref
Crossref
Nina G. Schneider, Scott Terrace, Margaret A. Koury, Shilpan Patel, Behram Vaghaiwalla, Regina Pendergrass, Richard E. Olmstead & Chris Cortner. (2005) Comparison of three nicotine treatments: initial reactions and preferences with guided use. Psychopharmacology 182:4, pages 545-550.
Crossref
Crossref
H. McRobbie, M. Lee & Z. Juniper. (2005) Non-nicotine pharmacotherapies for smoking cessation. Respiratory Medicine 99:10, pages 1203-1212.
Crossref
Crossref
A. Molero Chamizo & J.E. Muñoz Negro. (2005) Psicofarmacología de la nicotina y conducta adictiva. Trastornos Adictivos 7:3, pages 137-152.
Crossref
Crossref
Debra S. Harris & Robert M. Anthenelli. (2005) Expanding treatment of tobacco dependence. Current Psychiatry Reports 7:5, pages 344-351.
Crossref
Crossref
Thomas W. Klein. (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Reviews Immunology 5:5, pages 400-411.
Crossref
Crossref
Francis Barth. 2005. Annual Reports in Medicinal Chemistry Volume 40. Annual Reports in Medicinal Chemistry Volume 40
103
118
.
Arunabh Talwar, Mukesh Jain & V.K. Vijayan. (2004) Pharmacotherapy of tobacco dependence. Medical Clinics of North America 88:6, pages 1517-1534.
Crossref
Crossref